ACE2 and COVID-19: In relation to COVID-19, Liu et al. [59] reported that the infection of cultured human nasopharyngeal carcinoma cell line CNE-2Z or human embryonic kidney cell line 293 T with the H1N1 influenza A virus results in the downregulation of ACE2 protein.